PELTHOS THERAPEUTICS INC (PTHS) Stock Earnings Estimates

NYSEARCA:PTHS • US1711262048

23.24 USD
+1.11 (+5.02%)
Last: Feb 20, 2026, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PTHS revenue by date.PTHS revenue by date.
199.9KN/A
-100.00%		N/AN/AN/A19.363M68.561M
254.08%		131.1M
91.22%		207.69M
58.42%		230.52M
10.99%		271.56M
17.80%		238.43M
-12.20%		250.61M
5.11%		261.93M
4.52%
EBITDA
YoY % growth
PTHS ebitda by date.PTHS ebitda by date.
N/AN/AN/AN/AN/A-17.202B-19.987B
-16.19%		19.065B
195.39%		N/A71.204M80.147M
12.56%		89.773M
12.01%		98.325M
9.53%		106.19M
8.00%
EBIT
YoY % growth
PTHS ebit by date.PTHS ebit by date.
-1.354MN/A
38.03%		N/A
-176.31%		N/A
-196.02%		-7.036M
-2.53%		-35.033M
-397.91%		-24.378M
30.41%		11.891M
148.78%		54.8M
360.85%		76.89M
40.31%		102.95M
33.89%		89.773M
-12.80%		98.325M
9.53%		106.19M
8.00%
Operating Margin
PTHS operating margin by date.PTHS operating margin by date.
-677.29%N/AN/AN/AN/A-180.93%-35.56%9.07%26.39%33.36%37.91%37.65%39.23%40.54%
EPS
YoY % growth
PTHS eps by date.PTHS eps by date.
N/AN/AN/AN/A-13.26-17.51
-32.04%		-6.16
64.84%		2.35
138.22%		4.50
91.18%		7.03
56.24%		9.01
28.20%		10.87
20.68%		11.52
5.91%		12.01
4.25%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-3.92
-22.46%		-1.07
-260.34%		-0.93
82.75%		-0.56
89.51%		-0.56
85.68%
Revenue
Q2Q % growth		10.652M10.169M11.159M14.181M
91.48%		15.17M
42.41%
EBITDA
Q2Q % growth		-11.016MN/AN/AN/AN/A
EBIT
Q2Q % growth		-13.501M
-639.74%		-8.02M
-337.31%		-7.141M
-121.06%		-4.362M
7.73%		-3.482M
74.21%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -5.30
-82.76%		-0.44-4.86-1,108.39%
Q2 2025
Q2Q % growth		 -5.38
-73.55%		-6.391.0115.74%
Q1 2025
Q2Q % growth
47.27%		-0.30%
Q4 2024
Q2Q % growth		 -3.20 -2.14-1.06-49.39%
Q3 2024
Q2Q % growth		 -2.90 -2.35-0.55-23.61%
Q2 2024
Q2Q % growth		 -3.10 -2.96-0.14-4.80%
PTHS Yearly EPS VS EstimatesPTHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 -10 -15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 7.406M 4.467M2.939M65.79%
PTHS Yearly Revenue VS EstimatesPTHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% -0.22% N/A N/A